Dexmedetomidine Accord
Submitted by Anonymous (not verified) on 18 December 2024 - 11:17
Dexmedetomidine Accord
Seventh European Medicines Agency (EMA) and EFPIA bilateral meeting , European Medicines Agency, Amsterdam, the Netherlands, 29 November 2024
Submitted by Anonymous (not verified) on 18 December 2024 - 10:27
Seventh European Medicines Agency (EMA) and EFPIA bilateral meeting , European Medicines Agency, Amsterdam, the Netherlands, 29 November 2024
Highlights - Seventh European Medicines Agency (EMA) EFPIA bilateral meeting
Submitted by Anonymous (not verified) on 18 December 2024 - 10:25
Highlights - Seventh European Medicines Agency (EMA) EFPIA bilateral meeting
List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)
Submitted by Anonymous (not verified) on 18 December 2024 - 10:22
List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)
Third European Medicines Agency (EMA) and European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 7 November 2024
Submitted by Anonymous (not verified) on 18 December 2024 - 10:17
Third European Medicines Agency (EMA) and European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 7 November 2024
Highlights - Third European Medicines Agency (EMA) and European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) bilateral meeting
Submitted by Anonymous (not verified) on 18 December 2024 - 10:15
Highlights - Third European Medicines Agency (EMA) and European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) bilateral meeting
Human medicines European public assessment report (EPAR): Firdapse (previously Zenas), amifampridine, Date of authorisation: 23/12/2009, Revision: 22, Status: Authorised
Submitted by Anonymous (not verified) on 18 December 2024 - 10:14
Human medicines European public assessment report (EPAR): Firdapse (previously Zenas), amifampridine, Date of authorisation: 23/12/2009, Revision: 22, Status: Authorised
Keppra
Submitted by Anonymous (not verified) on 18 December 2024 - 10:10
Keppra
A common EU approach to data transparency in medicine regulation
Submitted by Anonymous (not verified) on 18 December 2024 - 10:00
A common EU approach to data transparency in medicine regulation
Heads of Medicines Agencies / European Medicines Agency guidance document on the identification of commercially confidential information and personal data within the structure of the marketing-authorisation application: ...
Submitted by Anonymous (not verified) on 18 December 2024 - 9:59
Heads of Medicines Agencies / European Medicines Agency guidance document on the identification of commercially confidential information and personal data within the structure of the marketing-authorisation application: ...